doxorubicin hydrochloride has been researched along with Leucocythaemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Chen, F; Chen, Y; Lin, Y; Wang, J; Zhang, L; Zhang, Z | 1 |
Chen, J; Gu, X; Guan, M; Jiang, C; Li, X; Qiu, J; Song, Q; Sun, N; Zhou, Q; Zou, Y | 1 |
Chen, C; Deng, Y; He, L; Hu, M; Li, B; Li, H; Yin, H; Zhang, J | 1 |
3 other study(ies) available for doxorubicin hydrochloride and Leucocythaemia
Article | Year |
---|---|
Design, synthesis and evaluation of the multidrug resistance-reversing activity of pyridine acid esters of podophyllotoxin in human leukemia cells.
Topics: Cell Line, Tumor; Drug Design; Drug Resistance, Multiple; Esters; Humans; Inhibitory Concentration 50; Leukemia; MAP Kinase Signaling System; Podophyllotoxin; Pyridines | 2016 |
Discovery of thiosemicarbazone-containing compounds with potent anti-proliferation activity against drug-resistant K562/A02 cells.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Proliferation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; K562 Cells; Leukemia; Reactive Oxygen Species; Thiosemicarbazones | 2020 |
Synthesis and antitumor activity of a series of novel N-aryl-5-(2,2,2-trifluoroethoxy)-1,5-dihydro-2H-pyrrol-2-ones derivatives.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Leukemia; Molecular Structure; Structure-Activity Relationship | 2022 |